Diabetic Eye Disease News and Research

RSS

Diabetic eye disease refers to a group of eye problems that people with diabetes may face as a complication of diabetes. All can cause severe vision loss or even blindness. Diabetic eye disease may include, diabetic retinopathy — damage to the blood vessels in the retina, Cataract—clouding of the eye's lens, glaucoma—increase in fluid pressure inside the eye that leads to optic nerve damage and loss of vision. A person with diabetes is nearly twice as likely to get glaucoma as other adults.

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exploristics’ cloud-based simulation platform KerusCloud used to enhance study design for Exonate’s upcoming Phase IIb study following successful Phase Ib/IIa study.

12 Mar 2024

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications.

5 Mar 2024

AI exam boosts diabetic eye screening rates in youth

A Johns Hopkins Children's Center study of children and youth with diabetes concludes that so-called autonomous artificial intelligence (AI) diabetic eye exams significantly increase completion rates of screenings designed to prevent potentially blinding diabetes eye diseases (DED).

11 Jan 2024

Can AI predict diabetic eye disease progression?

"DeepDR Plus," a deep learning system, accurately predicts diabetic retinopathy progression up to five years using fundus images, offering potential for personalized screening and management in diabetic patients.

7 Jan 2024

Two-year diabetic eye screening could lead to treatment delays and sight loss

Extending the annual screen to two years for people in England considered at low risk of diabetic eye disease could lead to critical treatment delays and sight loss, according to research led by St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust and involving Kingston University, London researchers and academics.

31 Oct 2023

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Extending the annual screen by a year for people in England considered to be at low risk of diabetic eye disease (diabetic retinopathy) could risk critical treatment delays and/or sight loss, suggests a large, real world data study, published online in the British Journal of Ophthalmology.

25 Oct 2023

Study reveals why hypoglycemic episodes worsen diabetic retinopathy

People with diabetes who experience periods of low blood sugar — a common occurrence in those new to blood sugar management — are more likely to have worsening diabetic eye disease.

26 Jan 2023

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

St George's, University of London and Moorfields Eye Hospital NHS Foundation Trust are leading a half a million pound project on artificial intelligence (AI), funded by NHSX and the Health Foundation, and enabled by the National Institute for Health Research.

22 Oct 2021

Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

People with type 2 diabetes diagnosed during youth have a high risk of developing complications at early ages and have a greater chance of multiple complications within 15 years after diagnosis.

28 Jul 2021

New biomarkers in the eyes could unlock the key to management of diabetic retinopathy

New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy, and perhaps even diabetes, according to new research conducted at the Indiana University School of Optometry.

26 Jul 2021

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

Diabetes continues to be the leading cause of new cases of blindness among adults in the United States. But the current shortage of eye-care providers would make it impossible to keep up with demand to provide the requisite annual screenings for this population.

5 Jan 2021

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Surgical and injectable drug approaches are equally effective for treatment of bleeding inside the eye from proliferative diabetic retinopathy (PDR), according to a National Eye Institute (NEI)-supported clinical study from the DRCR Retina Network (DRCR.net).

15 Dec 2020

Common medication used to treat diabetic macular edema is less effective in Black patients

A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.

22 Oct 2020

Artificial intelligence can detect serious eye disease in diabetic patients

Results from the largest study of artificial intelligence use in the English Diabetic Eye Screening Programme (DESP), have shown that the technology can accurately detect serious eye disease among those with diabetes (retinopathy) and could halve the human workload associated with screening for diabetic eye disease, saving millions of pounds annually.

6 Jul 2020

Diabetic Eye Disease News and Research

Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

AI exam boosts diabetic eye screening rates in youth

Can AI predict diabetic eye disease progression?

Two-year diabetic eye screening could lead to treatment delays and sight loss

Study: Extending diabetic eye screen to 2 years could risk critical treatment delays and sight loss

Study reveals why hypoglycemic episodes worsen diabetic retinopathy

New project to deploy AI technology for detecting sight-threatening diabetic eye disease

Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

New biomarkers in the eyes could unlock the key to management of diabetic retinopathy

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

Surgical and drug treatment approaches are equally effective for diabetic eye disease

Common medication used to treat diabetic macular edema is less effective in Black patients

Artificial intelligence can detect serious eye disease in diabetic patients

'Methylation clock' gene found to have functional role in aging of the eye

Survey uncovers key gaps in American's knowledge of eye health

A reality check on artificial intelligence: Are health care claims overblown?

UIC researchers to study the impact of chronic eye disease among Latinos

AI detects over 95 percent of diabetic retinopathy cases

How older adults can make life easier and safer despite declining vision

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News